BNP Paribas Financial Markets’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.66M Sell
76,754
-160,656
-68% -$3.47M ﹤0.01% 1949
2025
Q1
$3.94M Sell
237,410
-51,061
-18% -$848K ﹤0.01% 1365
2024
Q4
$5.29M Buy
288,471
+64,853
+29% +$1.19M ﹤0.01% 1198
2024
Q3
$3.44M Buy
223,618
+161,331
+259% +$2.48M ﹤0.01% 1173
2024
Q2
$1.01M Sell
62,287
-57,858
-48% -$940K ﹤0.01% 1656
2024
Q1
$2.22M Sell
120,145
-109,620
-48% -$2.03M ﹤0.01% 1459
2023
Q4
$7.19M Sell
229,765
-75,403
-25% -$2.36M 0.01% 829
2023
Q3
$6.36M Buy
305,168
+7,745
+3% +$161K 0.01% 768
2023
Q2
$7.12M Buy
297,423
+28,297
+11% +$678K 0.01% 764
2023
Q1
$5.06M Buy
269,126
+123,752
+85% +$2.33M 0.01% 902
2022
Q4
$2.31M Sell
145,374
-42,789
-23% -$681K ﹤0.01% 1183
2022
Q3
$3.08M Buy
188,163
+133,376
+243% +$2.18M ﹤0.01% 1176
2022
Q2
$772K Sell
54,787
-34,132
-38% -$481K ﹤0.01% 1812
2022
Q1
$2.15M Buy
88,919
+18,371
+26% +$445K ﹤0.01% 1330
2021
Q4
$1.65M Buy
70,548
+12,812
+22% +$299K ﹤0.01% 1687
2021
Q3
$959K Buy
57,736
+20,443
+55% +$340K ﹤0.01% 1873
2021
Q2
$910K Buy
37,293
+11,809
+46% +$288K ﹤0.01% 1723
2021
Q1
$657K Buy
25,484
+5,576
+28% +$144K ﹤0.01% 1904
2020
Q4
$1.06M Buy
19,908
+3,750
+23% +$200K ﹤0.01% 1425
2020
Q3
$667K Sell
16,158
-22,841
-59% -$942K ﹤0.01% 1496
2020
Q2
$1.89M Sell
38,999
-35,037
-47% -$1.7M ﹤0.01% 1084
2020
Q1
$3.13M Buy
74,036
+38,320
+107% +$1.62M 0.01% 881
2019
Q4
$1.53M Sell
35,716
-11,467
-24% -$491K ﹤0.01% 1287
2019
Q3
$1.7M Buy
47,183
+3,380
+8% +$122K ﹤0.01% 1124
2019
Q2
$1.17M Sell
43,803
-15,322
-26% -$410K ﹤0.01% 1181
2019
Q1
$1.59M Buy
59,125
+25,189
+74% +$676K ﹤0.01% 1063
2018
Q4
$549K Sell
33,936
-14,363
-30% -$232K ﹤0.01% 1201
2018
Q3
$1M Buy
48,299
+7,503
+18% +$156K ﹤0.01% 1224
2018
Q2
$623K Buy
40,796
+14,138
+53% +$216K ﹤0.01% 1362
2018
Q1
$599K Buy
26,658
+7,926
+42% +$178K ﹤0.01% 1580
2017
Q4
$564K Sell
18,732
-4,894
-21% -$147K ﹤0.01% 1785
2017
Q3
$890K Buy
23,626
+2,489
+12% +$93.8K ﹤0.01% 1468
2017
Q2
$590K Buy
21,137
+2,038
+11% +$56.8K ﹤0.01% 1598
2017
Q1
$657K Sell
19,099
-3,352
-15% -$115K ﹤0.01% 1372
2016
Q4
$647K Buy
22,451
+2,711
+14% +$78.2K ﹤0.01% 1316
2016
Q3
$628K Sell
19,740
-914
-4% -$29.1K ﹤0.01% 1110
2016
Q2
$670K Buy
20,654
+20,591
+32,684% +$668K ﹤0.01% 1362
2016
Q1
$1.76K Sell
63
-16,323
-100% -$456K ﹤0.01% 2435
2015
Q4
$584K Buy
16,386
+247
+2% +$8.81K ﹤0.01% 1294
2015
Q3
$534K Buy
16,139
+9,508
+143% +$314K ﹤0.01% 1318
2015
Q2
$278K Buy
6,631
+4,754
+253% +$199K ﹤0.01% 1568
2015
Q1
$61.2K Buy
+1,877
New +$61.2K ﹤0.01% 1862
2014
Q4
Sell
-4,740
Closed -$117K 1982
2014
Q3
$117K Buy
4,740
+4,387
+1,243% +$109K ﹤0.01% 1751
2014
Q2
$7.97K Buy
353
+287
+435% +$6.48K ﹤0.01% 1958
2014
Q1
$1.33K Sell
66
-844
-93% -$17K ﹤0.01% 2339
2013
Q4
$22.7K Sell
910
-18,398
-95% -$460K ﹤0.01% 1781
2013
Q3
$530K Sell
19,308
-8,991
-32% -$247K ﹤0.01% 1285
2013
Q2
$514K Buy
+28,299
New +$514K ﹤0.01% 1300